MARGARET BAKER
Nursing in Philadelphia, PA
License number
Pennsylvania RN052936L
Category
Nursing
Type
Registered Nurse
Address
Address
Philadelphia, PA 19124
Personal information
See more information about MARGARET BAKER at radaris.comName
Address
Phone
457 Derwyn Rd, Drexel Hill, PA 19026
490 Quiggley Cir, Harrisburg, PA 17112
4820 Christy Rd, Murrysville, PA 15668
42 Crouse Park, Littlestown, PA 17340
536 Edgeview Rd, New Kensington, PA 15068
Professional information
Project Manager At Merck
Position:
Project Manager at Merck
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
Merck
-
Project Manager
Treatment Of Gynecological Malignancies With Biologically Active Peptides
US Patent:
5635479, Jun 3, 1997
Filed:
May 2, 1995
Appl. No.:
8/434120
Inventors:
Leonard S. Jacob - Penn Valley PA
W. Lee Maloy - Lansdale PA
Margaret A. Baker - Philadelphia PA
W. Lee Maloy - Lansdale PA
Margaret A. Baker - Philadelphia PA
Assignee:
Magainin Pharmaceuticals Inc. - Plymouth Meeting PA
International Classification:
A61K 3600, C07K 1400
US Classification:
514 12
Abstract:
A process for treating a gynecological malignancy in a host which comprises administering to the host at least one biologically active amphiphilic peptide or protein. The peptide or protein may be administered intralesionally, intravenously, or intraperitoneally, whereby the peptide or protein may inhibit, prevent, or destroy the growth of the gynecological malignancy, such as an ovarian cancer, uterine cancer, or cervical cancer.
Method For Reducing Unwanted Cellular Adhesions
US Patent:
5480901, Jan 2, 1996
Filed:
Oct 7, 1994
Appl. No.:
8/320189
Inventors:
Margaret A. Baker - Philadelphia PA
Betsy M. Ohlsson-Wilhelm - Berwyn PA
Betsy M. Ohlsson-Wilhelm - Berwyn PA
Assignee:
Zynaxis, Inc. - Malvern PA
International Classification:
A01N 4338
US Classification:
514419
Abstract:
A conjugate comprising a drug which has an inhibitory effect on cellular adhesion and a lipophilic cell binding agent, when applied to a compromised site, e. g. , due to surgical intervention, injury, chemotherapy, disease or inflammation, is effective in reducing unwanted adhesion formation.